Charlotte's Web: Good Days Ahead

Summary

  • Charlotte's Web posted solid Q4 growth despite FDA guidelines holding back the CBD market.
  • The CBD specialist has several catalysts for growth in the years ahead, outside of domestic CBD sales.
  • The stock is cheap with a market valuation of $700 million, but investors should buy on dips due to FDA uncertainty.
  • This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More »

The market leader in the cannabidiol (CBD) space remains a stock to watch during a difficult regulatory period. Charlotte's Web Holdings (OTCQX:CWBHF) had a difficult 2020, but the company is poised to grow when the FDA finally sets guidelines surrounding CBD in dietary products. My investment thesis remains very bullish on the stock, especially on regulatory delay induced dips.

Image Source: Charlotte's Web website

Growing Despite FDA

Acquiring Abacus Health last year has helped the quarterly results, but the key is that CWBHF is positioned for success once the FDA provides new guidelines. The company now has 22,000 retail doors after adding another 1,100 in the last quarter.

For Q4, revenue reached a record high at $26.9 million. The numbers offered limited growth going all the way back to Q4 in 2019 when revenues hit $21.5 million. The revenue amount was up 7% sequentially from $25.2 million in the prior quarter as more consumers ordered online, but the main gain came from some retail and health practitioners reopening businesses.

Source: Charlotte's Web presentation

CWBHF now has a $100+ million annualized revenue run rate which is virtually EBITDA breakeven. For Q4, the adjusted EBITDA loss was only $2.1 million due to a 62% gross margin and cost controls.

The company lowered annualized operating expenses by $10 million in order to keep expenses in line with revenues here all while absorbing Abacus Health into the business. In addition, CWBHF opened up a new 137,000 sq. ft. facility to increase production capacity ahead of anticipated growth from updated FDA guidelines expected this year.

Big Days Ahead

The quarterly revenue levels are major disappointments for a company, when combined with Abacus Health, were once expected to generate over $100 million in quarterly revenues, or $400 million annually, by now. Though, investors need to remember that Charlotte's Web is better positioned now after

If you'd like to learn more about how to best position yourself in under valued stocks mispriced by the market, consider joining Out Fox The Street

The service offers model portfolios, daily updates, trade alerts and real-time chat. Sign up now for a risk-free, 2-week trial to start finding the next stock with the potential to double and triple in the next few years without taking on the risk of over priced momentum stocks. 

This article was written by

52.68K Followers

Stone Fox Capital is an RIA from Oklahoma. Mark Holder is a CPA with degrees in Accounting and Finance. He is also Series 65 licensed and has 30 years of investing experience, including 15 years as a portfolio manager.

Mark leads the investing group

Out Fox The Street

where he shares stock picks and deep research to help readers uncover potential multibaggers while managing portfolio risk via diversification. Features include various model portfolios, stock picks with identifiable catalysts, daily updates, real-time alerts, and access to community chat and direct chat with Mark for questions.

Learn more

.

Analyst’s Disclosure:I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CWBHF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CWBHF

Related Stocks

SymbolLast Price% Chg
CWBHF
--
CWEB:CA
--